Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stanford University
Research
ARPA-H awards up to $160M for custom genetic medicines
The most notable recipient is the Children’s Hospital of Philadelphia, which treated baby KJ with a groundbreaking custom gene therapy last year.
Darren Incorvaia
Jul 10, 2026 4:00am
Link emerges to connect CAR-T therapy across solid, liquid tumors
Dec 15, 2025 1:18pm
Natera buys Foresight Diagnostics in $450M cancer testing deal
Dec 5, 2025 11:57am
Harmless skin bacteria engineered to be living topical vaccine
Dec 11, 2024 11:00am
Stanford economist is Trump's NIH pick—Chutes & Ladders
Dec 6, 2024 8:30am
Trump taps Stanford economic researcher as NIH head
Nov 27, 2024 10:33am
